SPIE -- One of the promises of personalized medicine is the use of highly specific molecular therapies tailored to the genetic and molecular basis of an individual’s disease. While many conditions are diagnosed by a tissue biopsy, this is not always possible, and disease markers can vary over time or between biopsy locations, as is often the case for cancer.
